Functional dyspepsia, delayed gastric emptying, and impaired quality of life NJ Talley, GR Locke, BD Lahr, AR Zinsmeister, G Tougas, G Ligozio, ... Gut 55 (7), 933-939, 2006 | 363 | 2006 |
Medical application of millimetre waves. MA Rojavin, MC Ziskin QJM: monthly journal of the Association of Physicians 91 (1), 57-66, 1998 | 225 | 1998 |
Suppression of peritoneal macrophage phagocytosis of Candida albicans by opioids. I Szabo, M Rojavin, JL Bussiere, TK Eisenstein, MW Adler, TJ Rogers Journal of Pharmacology and Experimental Therapeutics 267 (2), 703-706, 1993 | 190 | 1993 |
Morphine treatment in vitro or in vivo decreases phagocytic functions of murine macrophages M Rojavin, I Szabo, JL Bussiere, TJ Rogers, MW Adler, TK Eisenstein Life sciences 53 (12), 997-1006, 1993 | 178 | 1993 |
C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks–final results of the IMPACT 2 study TJ Craig, AK Bewtra, SL Bahna, D Hurewitz, LC Schneider, RJ Levy, ... Allergy 66 (12), 1604-1611, 2011 | 165 | 2011 |
Efficacy and safety of a new 20% immunoglobulin preparation for subcutaneous administration, IgPro20, in patients with primary immunodeficiency JB Hagan, MB Fasano, S Spector, RL Wasserman, I Melamed, ... Journal of clinical immunology 30, 734-745, 2010 | 146 | 2010 |
Pharmacokinetics of subcutaneous immunoglobulin and their use in dosing of replacement therapy in patients with primary immunodeficiencies M Berger, M Rojavin, P Kiessling, O Zenker Clinical immunology 139 (2), 133-141, 2011 | 118 | 2011 |
Long‐term safety of tegaserod in patients with constipation‐predominant irritable bowel syndrome G Tougas, WJ Snape Jr, MH Otten, DL Earnest, KE Langaker, RE Pruitt, ... Alimentary pharmacology & therapeutics 16 (10), 1701-1708, 2002 | 101 | 2002 |
Reactions of keratinocytes to in vitro millimeter wave exposure I Szabo, MA Rojavin, TJ Rogers, MC Ziskin Bioelectromagnetics: Journal of the Bioelectromagnetics Society, The Society …, 2001 | 92 | 2001 |
Omeprazole delays gastric emptying in healthy volunteers: an effect prevented by tegaserod G Tougas, DL Earnest, Y Chen, C Vanderkoy, M Rojavin Alimentary pharmacology & therapeutics 22 (1), 59-65, 2005 | 80 | 2005 |
Pharmacokinetics of subcutaneous IgPro20 in patients with primary immunodeficiency RL Wasserman, I Melamed, RP Nelson, AP Knutsen, MB Fasano, ... Clinical pharmacokinetics 50, 405-414, 2011 | 73 | 2011 |
Suppression of pain sensation caused by millimeter waves: a double-blinded, cross-over, prospective human volunteer study AA Radzievsky, MA Rojavin, A Cowan, MC Ziskin Anesthesia & Analgesia 88 (4), 836-840, 1999 | 71 | 1999 |
Effect of time to treatment on response to C1 esterase inhibitor concentrate for hereditary angioedema attacks TJ Craig, MA Rojavin, T Machnig, HO Keinecke, JA Bernstein Annals of allergy, asthma & immunology 111 (3), 211-215, 2013 | 66 | 2013 |
Safety and usage of C1-inhibitor in hereditary angioedema: Berinert registry data MA Riedl, A Bygum, W Lumry, M Magerl, JA Bernstein, P Busse, T Craig, ... The Journal of Allergy and Clinical Immunology: In Practice 4 (5), 963-971, 2016 | 65 | 2016 |
Hypoalgesic effect of millimeter waves in mice: Dependence on the site of exposure AA Radzievsky, MA Rojavin, A Cowan, SI Alekseev, MC Ziskin Life sciences 66 (21), 2101-2111, 2000 | 64 | 2000 |
Peripheral neural system involvement in hypoalgesic effect of electromagnetic millimeter waves AA Radzievsky, MA Rojavin, A Cowan, SI Alekseev, AA Radzievsky Jr, ... Life Sciences 68 (10), 1143-1151, 2001 | 58 | 2001 |
Quantitative evidence of wear-off effect at the end of the intravenous IgG (IVIG) dosing cycle in primary immunodeficiency MA Rojavin, A Hubsch, JP Lawo Journal of clinical immunology 36, 210-219, 2016 | 51 | 2016 |
Antipruritic effect of millimeter waves in mice: evidence for opioid involvement MA Rojavin, A Cowan, AA Radzievsky, MC Ziskin Life sciences 63 (18), PL251-PL257, 1998 | 51 | 1998 |
Safety of a C1-inhibitor concentrate in pregnant women with hereditary angioedema J Fox, AB Vegh, I Martinez-Saguer, WA Wuillemin, J Edelman, ... Allergy and asthma proceedings 38 (3), 216-221, 2017 | 46 | 2017 |
Efficacy and safety of IgPro20, a subcutaneous immunoglobulin, in Japanese patients with primary immunodeficiency diseases H Kanegane, K Imai, M Yamada, H Takada, T Ariga, M Bexon, M Rojavin, ... Journal of Clinical Immunology 34, 204-211, 2014 | 45 | 2014 |